Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
52
CRARY Quote, Financials, Valuation and Earnings
Last price:
$6.75
Seasonality move
:
3.6%
Day range:
$6.64 - $6.77
52-week range:
$6.43 - $8.65
Dividend yield:
8.42%
P/E ratio:
6.68x
P/S ratio:
1.60x
P/B ratio:
0.54x
Volume:
329.7K
Avg. volume:
277.3K
1-year change:
-2.6%
Market cap:
$40.8B
Revenue:
$25.4B
EPS (TTM):
$1.01
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $21.4B | $20.6B | $25.3B | $21.8B | $25.4B | |
| Revenue Growth (YoY) | -3% | -3.9% | 23.05% | -14% | 16.62% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $14B | -$107.4M | $5.5B | -$1.1B | -$936.5M | |
| Operating Expenses | $14.3B | $14.7B | $16.3B | $14.8B | $16.2B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $6.7B | $5.2B | $9.6B | $8.3B | $10.3B | |
| Earnings of Discontinued Ops. | -$42.5M | -$252.4M | $5.9M | $127.6M | -$3.2M | |
| Income Tax Expense | $510.5M | $1.3B | $1.5B | $1.9B | $2.4B | |
| Net Income to Company | $6.7B | $5.2B | $9.6B | $8.3B | $10.3B | |
| Minority Interest in Earnings | -$687.4M | -$623.5M | -$1.2B | -$928M | -$1.1B | |
| Net Income to Common Excl Extra Items | $5.4B | $3.1B | $6.9B | $5.6B | $6.9B | |
| Basic EPS (Cont. Ops) | $0.83 | $0.46 | $1.09 | $0.86 | $1.05 | |
| Diluted EPS (Cont. Ops) | $0.83 | $0.46 | $1.09 | $0.86 | $1.05 | |
| Weighted Average Basic Share | $5.7B | $5.8B | $6B | $6B | $6.1B | |
| Weighted Average Diluted Share | $5.7B | $5.8B | $6B | $6B | $6.1B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $22B | $18.6B | $23.4B | $26.2B | $58.9B | |
| Revenue (Reported) | $21.4B | $20.6B | $25.3B | $21.8B | $25.4B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $22B | $18.6B | $23.4B | $26.2B | $58.9B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $6B | $6.5B | $5.4B | $7B | $7.1B | |
| Revenue Growth (YoY) | 7.25% | 8.17% | -17.61% | 30.12% | 2.13% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $3.5B | $3.8B | $3.2B | $3.7B | $4.1B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $1.9B | $2.5B | $2B | $2.9B | $2.6B | |
| Earnings of Discontinued Ops. | -$146.2M | -$3.5M | $123.9M | $2.2M | -- | |
| Income Tax Expense | $404.6M | $554.2M | $536.9M | $689.2M | $523.5M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$237.4M | -$266.5M | -$218.6M | -$273.3M | -$288.2M | |
| Net Income to Common Excl Extra Items | $1.1B | $1.7B | $1.3B | $1.9B | $1.8B | |
| Basic EPS (Cont. Ops) | $0.19 | $0.25 | $0.21 | $0.29 | $0.27 | |
| Diluted EPS (Cont. Ops) | $0.19 | $0.25 | $0.21 | $0.29 | $0.27 | |
| Weighted Average Basic Share | $5.8B | $6.1B | $6.1B | $6.1B | $6.1B | |
| Weighted Average Diluted Share | $5.8B | $6.1B | $6.1B | $6.1B | $6.1B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $1.9B | $2.5B | $2B | $2.9B | $2.6B | |
| Revenue (Reported) | $6B | $6.5B | $5.4B | $7B | $7.1B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $1.9B | $2.5B | $2B | $2.9B | $2.6B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $20B | $22.7B | $24B | $24.1B | $25.5B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $14.5B | $15.9B | $15.7B | $15.9B | $17.3B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $5.5B | $8.6B | $8.1B | $10.7B | $10.8B | |
| Earnings of Discontinued Ops. | -$198.2M | -$112M | $148.7M | -$17.9M | -$10.8M | |
| Income Tax Expense | -$149.4M | $2B | $1.6B | $2.3B | $2.3B | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$731M | -$1B | -$947.9M | -$1.1B | -$1.1B | |
| Net Income to Common Excl Extra Items | $4.7B | $5.4B | $5.7B | $7.3B | $7.3B | |
| Basic EPS (Cont. Ops) | $0.75 | $0.84 | $0.90 | $1.06 | $1.08 | |
| Diluted EPS (Cont. Ops) | $0.75 | $0.82 | $0.89 | $1.06 | $1.01 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $5.5B | $8.6B | $8.1B | $10.7B | $10.8B | |
| Revenue (Reported) | $20B | $22.7B | $24B | $24.1B | $25.5B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $5.5B | $8.6B | $8.1B | $10.7B | $10.8B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $15.5B | $19.5B | $18.8B | $19.9B | $20.9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $10.9B | $12.1B | $11.5B | $11.7B | $12.4B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $4.4B | $7.7B | $6.2B | $8.3B | $8.7B | |
| Earnings of Discontinued Ops. | -$147.3M | $2.5M | $145.3M | $8.7M | -- | |
| Income Tax Expense | $787.4M | $1.5B | $1.6B | $2B | $1.9B | |
| Net Income to Company | $2.5B | $5.2B | $3.8B | $5.4B | $6B | |
| Minority Interest in Earnings | -$553.8M | -$935.3M | -$691.7M | -$836.2M | -$874.2M | |
| Net Income to Common Excl Extra Items | $2.9B | $5.3B | $4.1B | $5.4B | $5.9B | |
| Basic EPS (Cont. Ops) | $0.45 | $0.83 | $0.64 | $0.83 | $0.86 | |
| Diluted EPS (Cont. Ops) | $0.45 | $0.82 | $0.64 | $0.83 | $0.79 | |
| Weighted Average Basic Share | $17.3B | $17.9B | $18.2B | $19.1B | $18.1B | |
| Weighted Average Diluted Share | $17.3B | $18.1B | $18.2B | $19.1B | $18.1B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $4.4B | $7.7B | $6.2B | $8.3B | $8.7B | |
| Revenue (Reported) | $15.5B | $19.5B | $18.8B | $19.9B | $20.9B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $4.4B | $7.7B | $6.2B | $8.3B | $8.7B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $479.7B | $691.1B | $725.6B | $702.3B | $662.1B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $588.1M | $674M | $995.2M | $1.4B | $1.6B | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $816.9B | $1.1T | $1.1T | $1.1T | $1.1T | |
| Property Plant And Equipment | $6.3B | $7.1B | $6.9B | $6.5B | $9.5B | |
| Long-Term Investments | $742B | $860B | $771.9B | $702.6B | $762.8B | |
| Goodwill | $17.1B | $18B | $17.7B | $16.8B | $17.6B | |
| Other Intangibles | $3.5B | $3.9B | $3.7B | $3.3B | $3.5B | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $2T | $2.4T | $2.3T | $2.3T | $2.4T | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $38B | $47.9B | $43.7B | $40.1B | $2.3B | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.9T | $2.3T | $2.3T | $2.2T | $2.3T | |
| Common Stock | $30.7B | $34.8B | $32.3B | $31.7B | $34.2B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $70.5B | $80.2B | $77.2B | $71.3B | $78.6B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $8.9B | $10.2B | $9.8B | $9.6B | $9.8B | |
| Total Equity | $79.4B | $90.4B | $87.1B | $80.9B | $88.3B | |
| Total Liabilities and Equity | $2T | $2.4T | $2.3T | $2.3T | $2.4T | |
| Cash and Short Terms | $479.7B | $691.1B | $725.6B | $702.3B | $662.1B | |
| Total Debt | $251.2B | $231.7B | $225.7B | $257.3B | $307.9B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $184.2B | $293.5B | $259.2B | $170.1B | -- | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $225.7B | $323.7B | $304.1B | $199.2B | -- | |
| Property Plant And Equipment | $6.2B | $7B | $10.5B | $14B | -- | |
| Long-Term Investments | $979.6B | $951B | $858.1B | $916.3B | -- | |
| Goodwill | $18.3B | $17.1B | $16B | $17.5B | -- | |
| Other Intangibles | $3.8B | $3.7B | $3.3B | $3.6B | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $2.3T | $2.4T | $2.5T | $2.6T | -- | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $4.8B | $3.9B | $2.9B | $3.2B | -- | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.2T | $2.3T | $2.3T | $2.4T | -- | |
| Common Stock | -- | -- | -- | $33.4B | -- | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $9.6B | $580M | $7.2B | $8B | -- | |
| Total Equity | $85.5B | $77.8B | $131.6B | $149B | -- | |
| Total Liabilities and Equity | $2.3T | $2.4T | $2.5T | $2.6T | -- | |
| Cash and Short Terms | $184.2B | $293.5B | $259.2B | $170.1B | -- | |
| Total Debt | $234B | $222.5B | $226.9B | $287.1B | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $6.7B | $5.2B | $9.6B | $8.3B | $10.3B | |
| Depreciation & Amoritzation | $1.2B | $1.3B | $1.4B | $1.2B | $1.2B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $7.7B | $65.4B | $12.9B | $1.5B | -$39.5B | |
| Capital Expenditures | $1.1B | $854.2M | $1B | $1.1B | $958.1M | |
| Cash Acquisitions | $8.1B | -$2.8B | $163.3M | -$3.8B | $11.6B | |
| Cash From Investing | $7B | -$3.7B | -$991.5M | -$5.3B | $10.7B | |
| Dividends Paid (Ex Special Dividend) | -$3B | -- | -$3.6B | -$3.4B | -$3.7B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$9M | -$142.8M | -$3.5M | $4B | $21.7B | |
| Cash From Financing | $2.5B | $8.8B | -$2B | $630.6M | $17.9B | |
| Beginning Cash (CF) | $83B | $103.7B | $178.9B | $168.4B | $168.3B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $17.2B | $70.5B | $9.9B | -$3.1B | -$10.9B | |
| Ending Cash (CF) | $101.6B | $172.7B | $189B | $163.9B | $154.4B | |
| Levered Free Cash Flow | $6.6B | $64.6B | $11.9B | $444M | -$40.5B | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.5B | $5.2B | $3.8B | $5.4B | $6B | |
| Depreciation & Amoritzation | $587M | $667.7M | $572M | $612.8M | $618.1M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $43.3B | $11.4B | $18.9B | -$43.8B | -$11.3B | |
| Capital Expenditures | $334.8M | $492.9M | $531.5M | $434M | $480.2M | |
| Cash Acquisitions | -$963.7M | $2.2B | -$1.4B | $877.8M | $260.6M | |
| Cash From Investing | -$1.3B | $1.7B | -$2.2B | $444.9M | -$219.7M | |
| Dividends Paid (Ex Special Dividend) | -$365.6M | -$2.7B | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $3.3M | -$120.5M | $1.3B | $12.4B | $20.3B | |
| Cash From Financing | $6.1B | -$1B | -$1.8B | $9.5B | $15.5B | |
| Beginning Cash (CF) | $100B | $182.2B | $170.1B | $169.5B | $153.5B | |
| Foreign Exchange Rate Adjustment | -$772M | -$631.5M | -$1.9B | -$4.3B | -$4.4B | |
| Additions / Reductions | $48.1B | $12.1B | $14.9B | -$33.8B | $4B | |
| Ending Cash (CF) | $147.3B | $193.7B | $183.1B | $131.3B | $153.2B | |
| Levered Free Cash Flow | $43B | $10.9B | $18.4B | -$44.2B | -$11.8B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | $334.8M | $492.9M | $531.5M | $434M | $480.2M | |
| Cash Acquisitions | -$963.7M | $2.2B | -$1.4B | $877.8M | $260.6M | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -$365.6M | -$2.7B | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.5B | $5.2B | $3.8B | $5.4B | $6B | |
| Depreciation & Amoritzation | $587M | $667.7M | $572M | $612.8M | $618.1M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $43.3B | $11.4B | $18.9B | -$43.8B | -$11.3B | |
| Capital Expenditures | $334.8M | $492.9M | $531.5M | $434M | $480.2M | |
| Cash Acquisitions | -$963.7M | $2.2B | -$1.4B | $877.8M | $260.6M | |
| Cash From Investing | -$1.3B | $1.7B | -$2.2B | $444.9M | -$219.7M | |
| Dividends Paid (Ex Special Dividend) | -$365.6M | -$2.7B | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $3.3M | -$120.5M | $1.3B | $12.4B | $20.3B | |
| Cash From Financing | $6.1B | -$1B | -$1.8B | $9.5B | $15.5B | |
| Beginning Cash (CF) | $100B | $182.2B | $170.1B | $169.5B | $153.5B | |
| Foreign Exchange Rate Adjustment | -$772M | -$631.5M | -$1.9B | -$4.3B | -$4.4B | |
| Additions / Reductions | $48.1B | $12.1B | $14.9B | -$33.8B | $4B | |
| Ending Cash (CF) | $147.3B | $193.7B | $183.1B | $131.3B | $153.2B | |
| Levered Free Cash Flow | $43B | $10.9B | $18.4B | -$44.2B | -$11.8B | |
Get CRARY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CRARY
Sector
P/E ratio
6.68x
11.99x
PEG ratio
1.41x
0.36x
P/B ratio
0.54x
1.05x
Price / LTM sales
1.60x
2.55x
Growth Metrics
CRARY
Sector
Revenue growth
2.13%
6.08%
Earnings growth
-4.71%
6.45%
Revenue (5-year growth)
2.85%
5.85%
Earnings forecast
--
$0.56
Profitability
CRARY
Sector
Profitability FY 2024
--
$179.9M
Return on invested capital
1.77%
5.27%
Return on assets
0.3%
0.98%
Return on equity
7.47%
9.43%
Earnings Date
Last Earnings Date
Nov
7
Next Earnings Date
Feb
7
Estimated Next Earnings Date
Feb
6
Balance Sheet
CRARY
Sector
Total cash
$631.8B
$615.3M
Short term investments
--
$408.4M
Total assets
$2.4T
$4.5B
Long term debt
--
$270.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
